Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal calprotectin for detection of checkpoint inhibitor-induced colitis
NL-OMON25248Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- May 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer, sponsored by Netherlands Cancer Institute. Primary endpoints: Fecal calprotectin levels and correlation with symptoms and endoscopic inflammation, Type of endoscopic and histological inflammation in patients with colitis and 2 more. Started May 2016; status: recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON25248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25248.